INOGEN INC (INGN) Stock Fundamental Analysis
USA - NASDAQ:INGN - US45780L1044 - Common Stock
6.88 USD
+0.29 (+4.4%)
6.88 USD
0 (0%)
INGN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. The financial health of INGN is average, but there are quite some concerns on its profitability. INGN is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
INGN had negative earnings in the past year.
In the past year INGN has reported a negative cash flow from operations.
In the past 5 years INGN always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: INGN reported negative operating cash flow in multiple years.
1.2 Ratios
INGN has a Return On Assets of -8.35%. This is in the better half of the industry: INGN outperforms 64.36% of its industry peers.
Looking at the Return On Equity, with a value of -13.06%, INGN is in the better half of the industry, outperforming 64.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.35% | ||
| ROE | -13.06% | ||
| ROIC | N/A |
ROA(3y)-21.41%
ROA(5y)-13.35%
ROE(3y)-32.95%
ROE(5y)-20.44%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Gross Margin value of 45.23%, INGN is not doing good in the industry: 61.17% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of INGN has remained more or less at the same level.
INGN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 45.23% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.22%
GM growth 5Y-0.6%
2. Health
2.1 Basic Checks
INGN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for INGN has been increased compared to 1 year ago.
Compared to 5 years ago, INGN has more shares outstanding
INGN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
Based on the Altman-Z score of 1.51, we must say that INGN is in the distress zone and has some risk of bankruptcy.
INGN has a Altman-Z score of 1.51. This is comparable to the rest of the industry: INGN outperforms 56.91% of its industry peers.
INGN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.51 |
ROIC/WACCN/A
WACC8.74%
2.3 Liquidity
INGN has a Current Ratio of 3.03. This indicates that INGN is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of INGN (3.03) is comparable to the rest of the industry.
INGN has a Quick Ratio of 2.67. This indicates that INGN is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.67, INGN is in the better half of the industry, outperforming 63.30% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.03 | ||
| Quick Ratio | 2.67 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 58.22% over the past year.
Looking at the last year, INGN shows a small growth in Revenue. The Revenue has grown by 6.35% in the last year.
INGN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.49% yearly.
EPS 1Y (TTM)58.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48%
Revenue 1Y (TTM)6.35%
Revenue growth 3Y-2.12%
Revenue growth 5Y-1.49%
Sales Q2Q%4%
3.2 Future
Based on estimates for the next years, INGN will show a very strong growth in Earnings Per Share. The EPS will grow by 23.99% on average per year.
INGN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.65% yearly.
EPS Next Y35.24%
EPS Next 2Y21.51%
EPS Next 3Y23.99%
EPS Next 5YN/A
Revenue Next Year7.96%
Revenue Next 2Y8.49%
Revenue Next 3Y6.65%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for INGN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for INGN. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
INGN's earnings are expected to grow with 23.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.51%
EPS Next 3Y23.99%
5. Dividend
5.1 Amount
INGN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
6.88
+0.29 (+4.4%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners74.25%
Inst Owner Change-2.52%
Ins Owners2.07%
Ins Owner Change1.59%
Market Cap186.04M
Revenue(TTM)335.70M
Net Income(TTM)-26.05M
Analysts82.5
Price Target13.26 (92.73%)
Short Float %2.88%
Short Ratio3.66
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)47.79%
Min EPS beat(2)44.85%
Max EPS beat(2)50.73%
EPS beat(4)4
Avg EPS beat(4)45.01%
Min EPS beat(4)33.97%
Max EPS beat(4)50.73%
EPS beat(8)6
Avg EPS beat(8)21.05%
EPS beat(12)9
Avg EPS beat(12)21.34%
EPS beat(16)11
Avg EPS beat(16)35.06%
Revenue beat(2)1
Avg Revenue beat(2)0.63%
Min Revenue beat(2)-0.15%
Max Revenue beat(2)1.4%
Revenue beat(4)3
Avg Revenue beat(4)2.75%
Min Revenue beat(4)-0.15%
Max Revenue beat(4)6.23%
Revenue beat(8)5
Avg Revenue beat(8)2.1%
Revenue beat(12)6
Avg Revenue beat(12)0.22%
Revenue beat(16)9
Avg Revenue beat(16)0.64%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)5.71%
EPS NQ rev (3m)1.49%
EPS NY rev (1m)0%
EPS NY rev (3m)6.91%
Revenue NQ rev (1m)0.07%
Revenue NQ rev (3m)0.44%
Revenue NY rev (1m)0.17%
Revenue NY rev (3m)0.61%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.54 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.93 | ||
| P/tB | 1.2 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.94
EYN/A
EPS(NY)-0.8
Fwd EYN/A
FCF(TTM)-0.83
FCFYN/A
OCF(TTM)-0.31
OCFYN/A
SpS12.7
BVpS7.38
TBVpS5.75
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.35% | ||
| ROE | -13.06% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 45.23% | ||
| FCFM | N/A |
ROA(3y)-21.41%
ROA(5y)-13.35%
ROE(3y)-32.95%
ROE(5y)-20.44%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.22%
GM growth 5Y-0.6%
F-Score6
Asset Turnover1.1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 66.83% | ||
| Cap/Sales | 4.05% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.03 | ||
| Quick Ratio | 2.67 | ||
| Altman-Z | 1.51 |
F-Score6
WACC8.74%
ROIC/WACCN/A
Cap/Depr(3y)106.82%
Cap/Depr(5y)105.29%
Cap/Sales(3y)6.42%
Cap/Sales(5y)6.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48%
EPS Next Y35.24%
EPS Next 2Y21.51%
EPS Next 3Y23.99%
EPS Next 5YN/A
Revenue 1Y (TTM)6.35%
Revenue growth 3Y-2.12%
Revenue growth 5Y-1.49%
Sales Q2Q%4%
Revenue Next Year7.96%
Revenue Next 2Y8.49%
Revenue Next 3Y6.65%
Revenue Next 5YN/A
EBIT growth 1Y51.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year103.09%
EBIT Next 3Y31.24%
EBIT Next 5YN/A
FCF growth 1Y59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y68.91%
OCF growth 3Y-36.98%
OCF growth 5Y-31.97%
INOGEN INC / INGN FAQ
What is the fundamental rating for INGN stock?
ChartMill assigns a fundamental rating of 3 / 10 to INGN.
What is the valuation status of INOGEN INC (INGN) stock?
ChartMill assigns a valuation rating of 1 / 10 to INOGEN INC (INGN). This can be considered as Overvalued.
How profitable is INOGEN INC (INGN) stock?
INOGEN INC (INGN) has a profitability rating of 2 / 10.
Can you provide the financial health for INGN stock?
The financial health rating of INOGEN INC (INGN) is 6 / 10.